The “PrEP APPEAL” of less frequent dosing: acceptability of six-monthly long acting-injectable PrEP among gay and other men who have sex with men and transgender women in Asia
Approximately one-third of Asian MSM and TGW were willing to use six-monthly LAI-PrEP, and it was the top preference for almost 20%. Offering a six-monthly LAI PrEP as an additional prevention choice could increase PrEP coverage and help meet unmet PrEP demand in Asia.
Authors
- Heather-Marie Ann Schmidt (ORCID: https://orcid.org/0000-0002-2629-6407)
- Nicky Suwandi
- Curtis Chan
- Hua Boonyapisomparn
- Lei Zhang
- Midnight Poonkasetwattana
- Benjamin R. Bavinton
- Nittaya Phanuphak
- Jason Ong
- Kimberly E. Green
- Warittha Tieosapjaroen
Institutions
- Family Health International 360 (US)
- Joint United Nations Programme on HIV/AIDS (CH)
- UNSW Sydney (AU)
- Melbourne Sexual Health Centre (AU)
- World Health Organization (CH)
- HIV Netherlands Australia Thailand Research Collaboration (TH)
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
- Alfred Health (AU)
- Monash University (AU)
- Xi'an Jiaotong University (CN)
Publication Details
- Journal
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2026-02-24
- DOI
- https://doi.org/10.1097/qai.0000000000003852
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 0.00